Planet Labs (PL) Stock Slides 2.6% Following CFO’s $7M Share Sale Despite Analyst Upgrades

Key Takeaways

• Planet Labs (PL) shares declined 2.6% during Monday’s session, reaching an intraday low of $34.21 before settling near $34.96.
• The company’s CFO and President, Ashley F. Johnson, offloaded 200,000 shares on April 2, generating approximately $7 million in proceeds.
• Fourth quarter fiscal 2026 revenue reached $86.82M—representing a 41.1% annual increase and exceeding analyst projections—though EPS significantly underperformed at ($0.48) versus the ($0.05) consensus.
• Multiple Wall Street firms increased their price targets, with Needham and Wedbush both moving to $40, while Citi upgraded to $35.
• The satellite imaging company also disclosed plans to redeem all outstanding public warrants on April 27, 2026, at a price of $0.01 per warrant.

Planet Labs (PL) experienced a 2.6% decline on Monday as market participants weighed a substantial insider transaction from a senior executive against the company’s latest quarterly performance.

Planet Labs PBC, PL

Ashley F. Johnson, who serves as both CFO and President, divested 200,000 Class A shares on April 2, collecting approximately $7 million from the transaction. The sale occurred in two separate blocks—51,460 shares were sold at prices ranging from $34.57 to $34.94, while another 148,540 shares moved at prices between $34.585 and $35.87.

Additionally, on April 6, Johnson executed a transfer of 525,708 shares to The Johnson Joint Revocable Trust, an entity controlled by Johnson and her spouse as co-trustees.

Insider selling activity has been notably active in recent months. Throughout the previous quarter, company insiders disposed of a combined 218,566 shares valued at approximately $5.9 million. Board member Vijaya Gadde also participated in January by selling 20,000 shares.

Such consistent selling activity often triggers caution among investors—regardless of whether underlying business metrics are strengthening.

Top Line Strength, Bottom Line Weakness

Planet Labs delivered fourth quarter fiscal 2026 revenue of $86.82 million, comfortably surpassing the $78.17 million consensus forecast. This represents a robust 41.1% increase compared to the prior year period.

However, the earnings picture proved less encouraging. The company reported an EPS loss of ($0.48), substantially worse than the ($0.05) loss analysts had anticipated. Planet Labs continues to operate at a loss, reflected in a negative net margin of 80.22% and a negative return on equity of 69.61%.

Looking ahead, management issued Q1 fiscal 2027 revenue guidance approximately 5% above Street expectations—a factor that contributed to maintaining positive analyst sentiment despite the earnings shortfall.

Goldman Sachs increased its price objective to $18 while maintaining a Neutral stance. Needham elevated its target to $40, highlighting revenue and EPS beats of 11% and $0.02 respectively, and reaffirmed its Buy recommendation. Wedbush similarly raised its target from $30 to $40 with an Outperform rating. Citi upgraded its target from $30 to $35 while maintaining a Buy rating.

Technical indicators show the stock’s 50-day moving average positioned at $26.21, with the 200-day average at $19.64—both substantially below Monday’s closing price.

Satellite Deployments and AI Integration

From an operational standpoint, Planet Labs recently delivered three Pelican satellites to Vandenberg Space Force Base in California, preparing for an upcoming SpaceX rideshare launch. These satellites are equipped with NVIDIA’s Jetson AI platform, enabling onboard data processing capabilities.

Warrant Redemption Notice

The company has declared its intention to redeem all outstanding public warrants for Class A common stock on April 27, 2026, at a redemption price of $0.01 per warrant.

Trading volume on Monday registered approximately 12.5 million shares—roughly 11% below the average daily volume of 14.1 million.

Planet Labs currently maintains a market capitalization of $12.10 billion, operates with a debt-to-equity ratio of 2.37, and exhibits a beta of 1.83.